Large-scale testing (Phase 3)Study completedNCT04346108
What this trial is testing
Immune Globulin Subcutaneous (Human), 20% Solution (IGSC, 20%) in Japanese Participants With Primary Immunodeficiency Diseases (PID)
Who this might be right for
Primary Immunodeficiency Diseases (PID)
Baxalta now part of Shire 17